Abstracts

HCV REINFECTION RISK FOLLOWING DAA THERAPY IN PEOPLE LIVING WITH HIV IN AUSTRALIA

Given unrestricted access to direct-acting antiviral (DAA) therapies from March 2016 in Australia, HCV elimination should be achievable among people living with HIV (PLWH). Increasing HCV risk behavior and HCV reinfection, however, have the potential to compromise HCV elimination. The Control and Elimination of HCV from HIV-infected individuals within Australia (CEASE-D) is an ongoing observational…

CARE FACILITATION FOR HIV/HCV COINFECTED INCREASES MOVEMENT ON THE HCV CARE CASCADE

HIV-HCV co-infection increases morbidity and mortality more than infection with either virus alone. CTN-0064 examined the efficacy of an HCV care-facilitation (CF) intervention on progression along the HCV care cascade. HIV-infected substance-using participants previously enrolled in CTN-0049 from 8 sites (Miami, FL, New York, NY, Atlanta, GA, Baltimore, MD, Boston, MA, Philadelphia, PA, Chicago, IL,…